Authors:
BIALER M
ARCAVI L
SUSSAN S
VOLOSOV A
YACOBI A
MOROS D
LEVITT B
LAOR A
Citation: M. Bialer et al., EXISTING AND NEW CRITERIA FOR BIOEQUIVALENCE EVALUATION OF NEW CONTROLLED-RELEASE (CR) PRODUCTS OF CARBAMAZEPINE, Epilepsy research, 32(3), 1998, pp. 371-378
Authors:
BIALER M
YACOBI A
MOROS D
LEVITT B
HOULE JM
MUNSAKA MS
Citation: M. Bialer et al., CRITERIA TO ASSESS IN-VIVO PERFORMANCE AND BIOEQUIVALENCE OF GENERIC CONTROLLED-RELEASE FORMULATIONS OF CARBAMAZEPINE, Epilepsia, 39(5), 1998, pp. 513-519
Authors:
RAINES A
FLOCKHART D
DRETCHEN KL
SINGH A
THACKER D
YACOBI A
MOROS D
LEVITT BH
ABERNETHY D
Citation: A. Raines et al., CONVERSION OF DIMETHOXYMETHYL-DIPHENYLBARBITURIC ACID (DMMDPB) TO DIPHENYLBARBITURIC ACID (DPB) IN THE RAT, The FASEB journal, 10(3), 1996, pp. 895-895
Authors:
MERCHANT CA
COHEN G
MYTILINEOU C
DIROCCO A
MOROS D
MOLINARI S
YAHR MD
Citation: Ca. Merchant et al., HUMAN TRANSPLACENTAL TRANSFER OF CARBIDOPA-LEVODOPA, Journal of neural transmission. Parkinson's disease and dementia section, 9(2-3), 1995, pp. 239-242
Citation: M. Serby et al., MAINTENANCE ECT AS ADJUNCTIVE TREATMENT TO DOPAMINERGIC DRUGS IN PARKINSONS-DISEASE, Biological psychiatry, 35(9), 1994, pp. 654-654